Illumina, Inc. (ILMN)
273.04
+7.32
(+2.75%)
USD |
NASDAQ |
Oct 02, 16:00
273.07
+0.03
(+0.01%)
After-Hours: 20:00
Illumina Enterprise Value : 42.59B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 42.59B |
| October 01, 2026 | 41.48B |
| September 30, 2026 | 42.68B |
| September 29, 2026 | 42.43B |
| September 28, 2026 | 42.42B |
| September 25, 2026 | 42.13B |
| September 24, 2026 | 42.72B |
| September 23, 2026 | 39.92B |
| September 22, 2026 | 38.73B |
| September 21, 2026 | 37.42B |
| September 18, 2026 | 37.54B |
| September 17, 2026 | 38.38B |
| September 16, 2026 | 35.93B |
| September 15, 2026 | 34.92B |
| September 14, 2026 | 32.80B |
| September 11, 2026 | 32.53B |
| September 10, 2026 | 31.75B |
| September 09, 2026 | 32.31B |
| September 08, 2026 | 33.23B |
| September 04, 2026 | 34.31B |
| September 03, 2026 | 34.83B |
| September 02, 2026 | 33.56B |
| September 01, 2026 | 32.64B |
| August 31, 2026 | 33.62B |
| August 28, 2026 | 33.91B |
| Date | Value |
|---|---|
| August 27, 2026 | 35.74B |
| August 26, 2026 | 35.31B |
| August 25, 2026 | 35.33B |
| August 24, 2026 | 35.07B |
| August 21, 2026 | 34.49B |
| August 20, 2026 | 33.56B |
| August 19, 2026 | 32.31B |
| August 18, 2026 | 29.79B |
| August 17, 2026 | 30.52B |
| August 14, 2026 | 30.18B |
| August 13, 2026 | 30.45B |
| August 12, 2026 | 30.49B |
| August 11, 2026 | 30.48B |
| August 10, 2026 | 30.32B |
| August 07, 2026 | 29.74B |
| August 06, 2026 | 30.61B |
| August 05, 2026 | 31.54B |
| August 04, 2026 | 32.01B |
| August 03, 2026 | 31.28B |
| July 31, 2026 | 32.33B |
| July 30, 2026 | 32.33B |
| July 29, 2026 | 30.78B |
| July 28, 2026 | 30.50B |
| July 27, 2026 | 29.97B |
| July 24, 2026 | 30.67B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 280.71B |
| Agilent Technologies, Inc. | 49.50B |
| Danaher Corp. | 173.98B |
| 10X Genomics, Inc. | 11.71B |
| Pacific Biosciences of California, Inc. | 1.259B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 207.00M |
| Revenue (Quarterly) | 1.161B |
| Total Expenses (Quarterly) | 954.00M |
| EPS Diluted (Quarterly) | 1.353 |
| Gross Profit Margin (Quarterly) | 66.49% |
| Profit Margin (Quarterly) | 17.83% |
| Earnings Yield | 1.97% |
| Operating Earnings Yield | 2.13% |
| Normalized Earnings Yield | 1.718 |